Navigation Links
Regeneron Announces September 2012 Investor Conference Presentations
Date:8/29/2012

TARRYTOWN, N.Y., Aug. 29, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations at the following investor conferences:

  • Robert W. Baird Healthcare Conference at 1:20 p.m. Eastern Time on Wednesday, September 5, 2012
  • Morgan Stanley Global Healthcare Conference at 3:55 p.m. Eastern Time on Tuesday, September 11, 2012
  • UBS Global Life Sciences Conference at 7:30 a.m. Eastern Time on Thursday, September 20, 2012
  • The sessions may be accessed through the Company's web site, www.regeneron.com, on the Events and Presentations page.  Archived versions of the presentations will be available for thirty days after the live webcasts. 

    Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection for Subcutaneous Use.  Regeneron has filed a regulatory application with the U.S. Food and Drug Administration (FDA) for a second indication for EYLEA.  Phase 3 studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727.  Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.  Additional information and recent news releases are available on the Regeneron web site at www.regeneron.com.Contact Information:Manisha Narasimhan, Ph.D.

    Peter DworkinInvestor Relations

    Corporate Communications914-847-5126

    914.847.764manisha.narasimhan@regeneron.com 

    peter.dworkin@regeneron.com


    '/>"/>
    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
    2. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
    3. Regeneron Announces June 2012 Investor Conference Presentations
    4. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
    5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
    7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
    8. Misonix Announces New Distribution Agreement For Panama
    9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
    10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/28/2017)... Calif. , Feb. 28, 2017  Rigel ... that it will report its fourth quarter and ... Tuesday, March 7, 2017.  Rigel senior management will ... and webcast at 5:00pm Eastern Time (2:00pm Pacific ... Participants can access the live conference call by ...
    (Date:2/28/2017)... YORK , Feb. 27, 2017  Market Research presents ... global medical fiber optics market titled ,Medical Fiber Optics Market: ... market dynamics and trends globally across the five key regions ... America , Europe , APAC and ... the global medical fiber optics market over the forecast period. ...
    (Date:2/28/2017)... LONDON , Feb. 27, 2017 This ... understand Takeda and its partnering interests and activities since ... Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
    Breaking Medicine Technology:
    (Date:2/27/2017)... ... February 27, 2017 , ... Anahata Ananda of Shamangelic ... happy to announce her “Spring Rejuvenation in Sedona” personally tailored retreats. For those ... the winter-weary soul an excellent opportunity to come out of hibernation and do ...
    (Date:2/27/2017)... ... ... Elisa Guajardo Carothers is not your typical author. She went from working as a movie ... writes about God, when she isn’t swimming as a performing mermaid. , Her book isn’t ... Satan),” she offers a comedic look at the dysfunctions of God’s family, before Lucifer was ...
    (Date:2/27/2017)... (PRWEB) , ... February 26, 2017 , ... Miro is ... pioneer sound and video system brings songs, movies, TV shows and much more apps ... offers clear, high-definition sound. An immersive view of 1280 x 720 provides crisp images ...
    (Date:2/27/2017)... BC (PRWEB) , ... February 27, 2017 , ... ... drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ ... to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to ...
    (Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the ... types and genders. And the need for advanced services is growing. , Project ... cancer care program, in collaboration with their non-profit partners in their fight against cancer ...
    Breaking Medicine News(10 mins):